Literature DB >> 11314016

NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps.

J C Hardwick1, G R van den Brink, G J Offerhaus, S J van Deventer, M P Peppelenbosch.   

Abstract

The factors that govern the progression from colonic adenomatous polyp to colon cancer are poorly understood. The observation that NSAIDs act as chemopreventative agents and reduce the size of colonic polyps suggests the involvement of inflammatory signalling, but inflammatory signalling in colonic polyps has not been studied. We investigated the expression of the active forms of NF-kappaB, JNK and p38 MAPK using immunohistochemistry with activation specific antibodies in human colonic adenomas. We show that active NF-kappaB is seen in stromal macrophages that also express COX-2 and TNF-alpha, active JNK is seen in stromal and intraepithelial T-lymphocytes and periendothelial cells of new blood vessels, and active p38 MAPK is most highly expressed in macrophages and other stromal cells. These results demonstrate the presence of active inflammatory signal transduction in colonic polyps and that these are predominantly in the stroma. In the case of NF-kappaB this coincides with the cellular localisation of COX-2. These results support evidence that NSAIDs may act through effects on stromal cells rather than epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314016     DOI: 10.1038/sj.onc.1204162

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  MAP kinase genes and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Roger K Wolff
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

3.  DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.

Authors:  Zhaoxia Qu; Pengrong Yan; Jing Fu; Jing Jiang; Michael J Grusby; Thomas E Smithgall; Gutian Xiao
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect.

Authors:  Yonghong Yang; Xingmin Wang; Thomas Huycke; Danny R Moore; Stanley A Lightfoot; Mark M Huycke
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

5.  JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.

Authors:  Michael P Lisanti; Aristotelis Tsirigos; Stephanos Pavlides; Kimberley Jayne Reeves; Maria Peiris-Pagès; Amy L Chadwick; Rosa Sanchez-Alvarez; Rebecca Lamb; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-12-05       Impact factor: 4.534

6.  The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines.

Authors:  Takaya Matsuzuka; Kathryn Miller; Lara Pickel; Chiyo Doi; Rie Ayuzawa; Masaaki Tamura
Journal:  Mol Cell Biochem       Date:  2008-10-01       Impact factor: 3.396

Review 7.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

8.  Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.

Authors:  Kara L Norman; Kensuke Hirasawa; An-Dao Yang; Michael A Shields; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism.

Authors:  Adrian W O'Sullivan; Jiang H Wang; Henry P Redmond
Journal:  World J Surg Oncol       Date:  2009-11-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.